Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06317363
Other study ID # REC/RCR&AHS/23/0353
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 23, 2023
Est. completion date February 15, 2024

Study information

Verified date March 2024
Source Riphah International University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Coronary artery bypass grafting (CABG) is a surgical procedure that is performed to improve blood flow to the heart by bypassing blocked or narrowed arteries. CABG is a major surgery that is associated with significant postoperative complications, including pulmonary complications such as atelectasis and pneumonia. Chest physiotherapy is commonly use to prevent and treat these complications, but its effectiveness in post-operative CABG patients is not well established. The purpose of this study is to evaluate the effects of Acapella device vs chest physiotherapy on pulmonary function, airway clearance and dyspnea in post-operative CABG patients. The group A will receive (baseline treatment aerosol therapy, ACBT, Mobilization, breathing with arm elevation with addition to using Acapella), while the group B will receive base line treatment. aerosol therapy, ACBT, Mobilization, breathing with arm elevation with addition chest physiotherapy percussing for 20 minute The primary outcome measures of the study will be pulmonary function tests, including forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and FEV1/FVC, and Modified Borg dyspnea scale . The secondary outcome measures will be the amount of sputum cleared. The study will be conducted over a period of 6 months after approval of synopsis. The study will be conducted in a tertiary care hospital in Lahore, Pakistan. Patients who have undergone CABG surgery will be screen for eligibility and those who meet the inclusion criteria will be enroll in the study. Patients who have a history of chronic lung disease, smoking, intubated patient or other respiratory conditions will be exclude from the study


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date February 15, 2024
Est. primary completion date January 30, 2024
Accepts healthy volunteers No
Gender All
Age group 55 Years to 70 Years
Eligibility Inclusion Criteria: - both gender - Patients aged between 55-70 years - Vitally Stable - extubated post-CABG day 01 patients - Patient undergone for the 1st time CABG Exclusion Criteria: - With a history of chronic obstructive pulmonary disease or asthma patient - Intubated patient - Surgical complication after CABG - With a history of smoking - Patients who have undergone thoracic surgery in the past - Patients with a history of neuromuscular disorders - Patients with a history of heart failure - Vitally unstable or on ventilator post CABG patients

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Base Line + ACEPELLA
Group A (baseline treatment + acapella) consisting of 15 participants will receive (baseline treatment aerosol therapy, ACBT, Mobilization, breathing with arm elevation with addition to using Acapella). The primary and secondary outcome measures will be assessed at baseline post-op day 1, and after 1 week of surgery.
Base Line + Manual Chest Physiotherapy
The group B consisting of 15 participants will receive base line treatment. aerosol therapy, ACBT, Mobilization, breathing with arm elevation with addition chest physiotherapy percussing for 20 minute. The s primary and secondary outcome measures will be assessed at baseline post-op day 1, and after 1 week of surgery.

Locations

Country Name City State
Pakistan Jinnah Hospital Lahore Punjab

Sponsors (1)

Lead Sponsor Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

References & Publications (7)

Chen X, Li C, Zeng L, Rong T, Lin P, Wang Q, Guo Z, Long H, Zhong J. Comparative efficacy of different combinations of acapella, active cycle of breathing technique, and external diaphragmatic pacing in perioperative patients with lung cancer: a randomised controlled trial. BMC Cancer. 2023 Mar 28;23(1):282. doi: 10.1186/s12885-023-10750-4. — View Citation

Farina P, Gaudino MFL, Taggart DP. The Eternal Debate With a Consistent Answer: CABG vs PCI. Semin Thorac Cardiovasc Surg. 2020 Spring;32(1):14-20. doi: 10.1053/j.semtcvs.2019.08.009. Epub 2019 Aug 20. — View Citation

Jannati M, Navaei MR, Ronizi LG. A comparative review of the outcomes of using arterial versus venous conduits in coronary artery bypass graft (CABG). J Family Med Prim Care. 2019 Sep 30;8(9):2768-2773. doi: 10.4103/jfmpc.jfmpc_367_19. eCollection 2019 Sep. — View Citation

Moradian ST, Heydari AA, Mahmoudi H. What is the Role of Preoperative Breathing Exercises in Reducing Postoperative Atelectasis after CABG? Rev Recent Clin Trials. 2019;14(4):275-279. doi: 10.2174/1574887114666190710165951. — View Citation

Rupprecht L, Schmid C, Debl K, Lunz D, Florchinger B, Keyser A. Impact of coronary angiography early after CABG for suspected postoperative myocardial ischemia. J Cardiothorac Surg. 2019 Mar 12;14(1):54. doi: 10.1186/s13019-019-0876-0. — View Citation

Shawon MSR, Odutola M, Falster MO, Jorm LR. Patient and hospital factors associated with 30-day readmissions after coronary artery bypass graft (CABG) surgery: a systematic review and meta-analysis. J Cardiothorac Surg. 2021 Jun 10;16(1):172. doi: 10.1186/s13019-021-01556-1. — View Citation

Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Matsumura-Nakano Y, Nakatsuma K, Watanabe H, Yamamoto E, Kato E, Fuki M, Yamaji K, Nishikawa R, Nagao K, Takeji Y, Watanabe H, Tazaki J, Watanabe S, Saito N, Yamazaki K, Soga Y, Komiya T, Ando K, Minatoya K, Furukawa Y, Nakagawa Y, Kadota K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 investigators. Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3). Am J Cardiol. 2021 Mar 1;142:35-43. doi: 10.1016/j.amjcard.2020.11.031. Epub 2020 Dec 3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Modified Borg Dyspnea Scale It is a subjective tool to assess degree of dyspnea in patients. The comprise of 10 grades starting from zero to 10. Zero refers to 'No difficulty in breathing at all 'and 10 refers to 'maximal difficulty ' Readings will be taken at 1st post op day and after post op week 1 1 week
Primary FEV1 digital spirometer device will be used to take readings of lung volumes in (ml). These measurements are part of a pulmonary function test, which helps diagnose and monitor respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Readings will be taken at 1st post op day and after 1st post op week 1 week
Primary FVC digital spirometer device will be used to take readings of lung capacities in (ml). These measurements are part of a pulmonary function test, which helps diagnose and monitor respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Readings will be taken at 1st post op day and after 1st post op week 1 week
Primary FEV1/FVC digital spirometer device will be used to take readings of FEV1/FVC. Readings will be taken at 1st post op day and after 1st post op week 1 week
Primary sputum volume A sputum collection jar will be used to record the amount of sputum produced by a patient over a specific period of time in (ml). Sputum is a mixture of saliva and mucus that is expectorated from the lungs. By tracking the amount and consistency of sputum, healthcare professionals can monitor the progression of respiratory conditions and assess the effectiveness of treatment.
The readings of these outcome measure will be taken two times. 1st post op day and after 1st week
1 Weeks
Secondary body temperature(degree centigrade) Pre-post readings of vitals will be taken from monitor attached to the patient 1 week
Secondary pulse rate (beats/minute) Pre-post readings of vitals will be taken from monitor attached to the patient 1 week
Secondary respiratory rate( breaths/minute) Pre-post readings of vitals will be taken from monitor attached to the patient 1 week
Secondary blood pressure (mmHg) Pre-post readings of vitals will be taken from monitor attached to the patient 1 week
Secondary SpO2 (%) pre-post readings will be taken of oxygenic indicators through ABGs 1 week
Secondary SaO2 (%) pre-post readings will be taken of oxygenic indicators through ABGs 1 week
Secondary PaO2 (%) pre-post readings will be taken of oxygenic indicators through ABGs 1 week
Secondary PaCO2 (%) pre-post readings will be taken of oxygenic indicators through ABGs 1 week
See also
  Status Clinical Trial Phase
Completed NCT01956708 - Transfer of Cardioprotection During RIPC N/A
Completed NCT01928745 - Experimental Determination of Atot en Ka in the Critically Ill N/A
Active, not recruiting NCT00966654 - Effect of GLP - 1 (7-36 Amide) on Myocardial Function Following Coronary Artery Bypass (CABG) Surgery Phase 2
Completed NCT00524901 - Study of the Use of a Single Dose of Erythropoietin to Treat Acute Myocardial Ischemia Phase 2
Completed NCT01282671 - Effects of Deep Breathing Exercises Two Months After Cardiac Surgery Phase 2
Completed NCT03050489 - Assessment of Myocardial Ischemic-Reperfusion Injury During Off- and On- Pump CABG
Recruiting NCT06124937 - Empagliflozin to Prevent Post-Operative Atrial Fibrillation Phase 3
Completed NCT00269243 - Management With Accupril Post Bypass Graft Phase 4
Recruiting NCT03139929 - Measurement of MSFP and Stressed Volume With CardioQ+®
Active, not recruiting NCT03424941 - The TransCatheter Valve and Vessels Trial N/A
Completed NCT05023083 - Cross Cultural Adaptation of Functional Status Questionnaire in Urdu Language in CABG Patients
Completed NCT03800264 - Bisoprolol Versus Corticosteroid and Bisoprolol Combination for Prophylaxis Against Atrial Fibrillation After on Pump Coronary Artery Bypass Surgery Phase 4
Completed NCT05285865 - Scapular Mobilization on Inspiratory Capacity of Post-CABG Patients N/A
Not yet recruiting NCT06173609 - Long LIMA Patch on Left Anterior Descending Coronary Artery in CABG
Not yet recruiting NCT06238011 - Dexmedetomidine vs Control on Attenuation Hemodynamic Response to Noxious Stimuli in CABG Surgical Patients N/A
Active, not recruiting NCT06127147 - High-intensity Inspiratory Muscle Training as a Pre-cardiac Rehabilitation in Heart Disease N/A
Recruiting NCT06029556 - Effects of Early Mobility Protocols in Cardiac ICU N/A
Enrolling by invitation NCT01205620 - IRB-HSR# 15084 A Prospective, Unblinded, Controlled Study to Evaluate the Effect of the ITPR in Patients Undergoing OPCAB Surgery Phase 2